These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 4999558)

  • 41. [The prevention of rhesus immunization with anti-rhesus (D) immunoglobulin. Report of a clinical study carried out in Dutch hospitals].
    Dudok De Wit C; Borst-Eilers E; van der Weerdt CM; Kloosterman GJ
    Ned Tijdschr Geneeskd; 1968 Dec; 112(52):2345-51. PubMed ID: 4974070
    [No Abstract]   [Full Text] [Related]  

  • 42. [Prevention of D-sensitization after administration of Rh-positive blood in a Rh-negative receptor].
    Dieckmann W; Schneider W; Schunter F; Zapata M
    Med Welt; 1971 Jan; 3():116-8. PubMed ID: 4993562
    [No Abstract]   [Full Text] [Related]  

  • 43. Prevention of maternal sensitization to the Rh factor.
    N Engl J Med; 1972 Jul; 287(4):197-8. PubMed ID: 4624455
    [No Abstract]   [Full Text] [Related]  

  • 44. Prevention of Rh immunization in Germany.
    Schneider J
    Pathologica; 1972; 64(929):105-9. PubMed ID: 4210234
    [No Abstract]   [Full Text] [Related]  

  • 45. [Observations concerning the prevention of rhesus immunization in the Netherlands].
    de Bruijne JI; van der Weerdt CM; Stallman HF; Hartgerink MJ; borst-Eilers E; Dudok de Wit C
    Ned Tijdschr Geneeskd; 1968 Dec; 112(52):2367-70. PubMed ID: 4974071
    [No Abstract]   [Full Text] [Related]  

  • 46. [Prevention of hemolytic disease of the newborn with anti-D administration to the mother. 2].
    Dtsch Med Wochenschr; 1968 Jun; 93(24):1176-9. PubMed ID: 4967928
    [No Abstract]   [Full Text] [Related]  

  • 47. Some epidemiological aspects of the prevention of Rh isoimmunization.
    Walker W
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):431-5. PubMed ID: 5003520
    [No Abstract]   [Full Text] [Related]  

  • 48. Epidemiology of Rh hemolytic disease of the newborn, United States, 1960-1979.
    Adams MM; Gustafson J
    Prog Clin Biol Res; 1981; 70():213-7. PubMed ID: 6273934
    [No Abstract]   [Full Text] [Related]  

  • 49. [Prevention of fetomaternal immunization].
    Mahon R
    Maroc Med; 1968 Feb; 48(510):63-7. PubMed ID: 4983301
    [No Abstract]   [Full Text] [Related]  

  • 50. [The present status of prevention of Rh sensitization with anti-D sera].
    Preisler O; Schneider J
    Geburtshilfe Frauenheilkd; 1966 May; 26(5):732-4. PubMed ID: 4956775
    [No Abstract]   [Full Text] [Related]  

  • 51. A landmark in medical progress: prevention of Rh sensitization.
    N Engl J Med; 1967 Nov; 277(19):1036-7. PubMed ID: 4964672
    [No Abstract]   [Full Text] [Related]  

  • 52. [Immune-prevention of fetal erythroblastosis].
    Schubert W
    Z Arztl Fortbild (Jena); 1971 Jun; 65(11):540-5. PubMed ID: 4998879
    [No Abstract]   [Full Text] [Related]  

  • 53. [Immunosuppression of anti-Rh antibodies: mechanism of action and times of administration of the anti-D immunoglobulins].
    Carretti N
    Attual Ostet Ginecol; 1968; 1():181-92. PubMed ID: 4194920
    [No Abstract]   [Full Text] [Related]  

  • 54. [Importance of systematic detection and identification of irregular antibodies in pregnant women where anti D+ jka immunization is recognized tardily].
    Baumes RM; Muller F; Aneflous B; Bouakline D
    Voen Med Zh; 1970 Aug; 8():458-64. PubMed ID: 4995496
    [No Abstract]   [Full Text] [Related]  

  • 55. [Importance of systematic detection and identification of irregular antibodies in pregnant women where anti D+ jka immunization is recognized tardily].
    Baumes RM; Muller F; Aneflous B; Bouakline D
    Maroc Med; 1970 Jul; 537():458-64. PubMed ID: 4993873
    [No Abstract]   [Full Text] [Related]  

  • 56. [Prevention of Rh immunization in Finland. Results obtained in a two-year national anti-D programme].
    Eklund J; Nevanlinna HR
    Duodecim; 1971; 87(10):861-6. PubMed ID: 4998010
    [No Abstract]   [Full Text] [Related]  

  • 57. [Current methods of treatment and prevention of Rh-immunization and erythroblastosis].
    Ruponen S
    Suom Laakaril; 1966 Jul; 21(20):1695-8. PubMed ID: 4961256
    [No Abstract]   [Full Text] [Related]  

  • 58. [Immunologic aspects of plasmapheresis in series of Rh negative pregnant women].
    Correa N; Goméz G; Rubinstein P
    Rev Chil Obstet Ginecol; 1976; 41(7):257-8. PubMed ID: 829286
    [No Abstract]   [Full Text] [Related]  

  • 59. [Antenatal treatment of maternal-fetal Rh incompatibility hemolysis disease].
    Zhao L; Huang X; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jul; 33(7):406-8. PubMed ID: 10806699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rhesus and other antibodies.
    O'Sullivan JF
    Clin Obstet Gynaecol; 1982 Apr; 9(1):91-9. PubMed ID: 6809392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.